Auteurs

Paolo Palmigiano

Associé

Read More

Louisa Penny

Senior counsel

Read More
Auteurs

Paolo Palmigiano

Associé

Read More

Louisa Penny

Senior counsel

Read More

Relaxed European competition rules to ensure supply and distribution of scarce products

  • QUICK READ

Recent developments in European competition law against the background of the COVID-19 crisis that may be important for your company.

To avoid shortages in the supply of key medicines and medical equipment, on 8 April 2020, the European Commission announced a temporary relaxation of the relevant European competition rules and now allows for limited business cooperation between pharmaceutical companies and medical equipment producers to meet demand.

Notably, the Commission's Temporary Framework is intended to ensure hospitals are supplied with medicines and equipment for coronavirus patients.

The Commission will also issue so-called "comfort letters" concerning a specific cooperation project aimed at avoiding shortages of critical hospital medicines. The Temporary Framework explains when and how firms can obtain guidance or written comfort in accordance with competition rules.

Furthermore, the Temporary Framework provides that manufacturers may coordinate more closely than normally permitted under European antitrust rules. This may apply to production, warehousing and possibly coordination of distribution, so that not all companies concentrate on one or a few medicines while other medicines are not produced in sufficient quantities.

The communication on the Temporary Framework sets out the main criteria that the Commission will use when considering these possible cooperation projects. In particular, the Commission will not take action if the cooperation project is:

  • objectively necessary to actually increase output in the most efficient way to address or avoid a shortage of supply of essential products or services (such as those that are used to treat COVID-19 patients)
  • temporary in nature (ie to be applied only as long there is a risk of shortage or in any event during the COVID-19 outbreak), and
  • not exceeding what is strictly necessary to achieve the objective of addressing or avoiding the shortage of supply.

If you have any questions regarding the Temporary Framework, or should you require assistance with related or general antitrust law issues, please contact a member of our Competition, EU and Trade team.

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Concurrence, UE & commerce

Labour markets in the spotlight of competition authorities

24 mai 2023
Briefing

par Paolo Palmigiano et Louisa Penny

Cliquer ici pour en savoir plus
Concurrence, UE & commerce

Wide most favourite nation clauses and the Competition Appeal Tribunal's judgement on appeal by Compare The Market

22 août 2022
Briefing

par Paolo Palmigiano

Cliquer ici pour en savoir plus
Concurrence, UE & commerce

Changes to the rules on foreign investment and national security in the UK and the EU

4 août 2022
In-depth analysis

par Paolo Palmigiano

Cliquer ici pour en savoir plus